FoxO function PAR excellence…

 

T&H Insight on ► Mahajan et al. Thromb Haemost 2012; 108: 148-159..

• References

• 1 Jarvis LM. Controlling the code – companies make headway in understanding epigenetic targets and designing drugs to modulate them. Chem Eng News 2012; 90: 12-19.
• 2 Mahajan S, Fender A, Meyer-Kirchrath J. et al. A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation. Thromb Haemost 2012; 108: 148-159.
• 3 Oellerich M F, Potente M. FOXOs and sirtuins in vascular growth, maintenance, and aging. Circ Res 2012; 110: 1238-1251.
• 4 Wan S, George SJ, Berry C. et al. Vein graft failure: current clinical practice and potential for gene therapeutics. Gene Ther. 2012 in press.